New directions in asthma drug therapy

被引：2

作者：

Drazen, JM ^{[1
]}

机构：

[1] Harvard Univ, Sch Med, Boston, MA 02115 USA

来源：

HOSPITAL PRACTICE | 1998年 / 33卷 / 02期

关键词：

D O I：

10.1080/21548331.1998.11443632

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

A new generation of biologically informative treatments has altered our understanding of the disease-transforming what used to be viewed as a single entity into a family of airway disorders driven by different proinflammatory mediators. Although inhaled corticosteroids have been the treatment of choice for most patients, research is increasingly aimed at developing inhibitors targeted to specific effector systems.

引用

收藏

页码：25 / +

页数：8

相关论文

共 11 条

[1] Prolonged protection against exercise-induced bronchoconstriction by the leukotriene D-4-receptor antagonist cinalukast [J].

Adelroth, E ;

Inman, MD ;

Summers, E ;

Pace, D ;

Modi, M ;

OByrne, PM .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1997, 99 (02) :210-215

[2]

DRAZEN JM, 1988, ANN NY ACAD SCI, V524, P289

[3] EFFECT OF CHRONIC 5-LIPOXYGENASE INHIBITION ON AIRWAY HYPERRESPONSIVENESS IN ASTHMATIC SUBJECTS [J].

FISCHER, AR ;

MCFADDEN, CA ;

FRANTZ, R ;

AWNI, WM ;

COHN, J ;

DRAZEN, JM ;

ISRAEL, E .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1995, 152 (04) :1203-1207

[4] THE ROLE OF LEUKOTRIENES IN INFLAMMATION [J].

HENDERSON, WR .

ANNALS OF INTERNAL MEDICINE, 1994, 121 (09) :684-697

[5] Leukotriene antagonists and synthesis inhibitors: New directions in asthma therapy [J].

Holgate, ST ;

Bradding, P ;

Sampson, AP .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1996, 98 (01) :1-13

[6] THE PIVOTAL ROLE OF 5-LIPOXYGENASE PRODUCTS IN THE REACTION OF ASPIRIN-SENSITIVE ASTHMATICS TO ASPIRIN [J].

ISRAEL, E ;

FISCHER, AR ;

ROSENBERG, MA ;

LILLY, CM ;

CALLERY, JC ;

SHAPIRO, J ;

COHN, J ;

RUBIN, P ;

DRAZEN, JM .

AMERICAN REVIEW OF RESPIRATORY DISEASE, 1993, 148 (06) :1447-1451

[7] THE EFFECT OF INHIBITION OF 5-LIPOXYGENASE BY ZILEUTON IN MILD-TO-MODERATE ASTHMA [J].

ISRAEL, E ;

RUBIN, P ;

KEMP, JP ;

GROSSMAN, J ;

PIERSON, W ;

SIEGEL, SC ;

TINKELMAN, D ;

MURRAY, JJ ;

BUSSE, W ;

SEGAL, AT ;

FISH, J ;

KAISER, HB ;

LEDFORD, D ;

WENZEL, S ;

ROSENTHAL, R ;

COHN, J ;

LANNI, C ;

PEARLMAN, H ;

KARAHALIOS, P ;

DRAZEN, JM .

ANNALS OF INTERNAL MEDICINE, 1993, 119 (11) :1059-1066

[8] Acute and chronic effects of a 5-lipoxygenase inhibitor in asthma: A 6-month randomized multicenter trial [J].

Liu, MC ;

Dube, LM ;

Lancaster, J .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1996, 98 (05) :859-871

[9] Antileukotrienes in the treatment of asthma [J].

OByrne, PM ;

Israel, E ;

Drazen, JM .

ANNALS OF INTERNAL MEDICINE, 1997, 127 (06) :472-480

[10] EFFECTS OF 6 WEEKS OF THERAPY WITH ORAL DOSES OF ICI-204,219, A LEUKOTRIENE D-4 RECEPTOR ANTAGONIST, IN SUBJECTS WITH BRONCHIAL-ASTHMA [J].

SPECTOR, SL ;

SMITH, LJ ;

GLASS, M ;

BIRMINGHAM, BK ;

BRONSKY, EA ;

DUNN, KD ;

FISH, JE ;

GROSSMAN, J ;

HOWLAND, W ;

MINKWITZ, MC ;

LARSEN, JS ;

NATHAN, RA ;

RENNARD, SI ;

SCHULMAN, ES ;

SEGAL, A ;

SELTZER, LM .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1994, 150 (03) :618-623